Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features

Alessandra Balduzzi, Emilia Montagna, Vincenzo Bagnardi, Rosalba Torrisi, Francesco Bertolini, Patrizia Mancuso, Eloise Scarano, Giuseppe Viale, Paolo Veronesi, Anna Cardillo, Laura Orlando, Aron Goldhirsch, Marco Colleoni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features'. Together they form a unique fingerprint.

Medicine & Life Sciences